Literature DB >> 10230738

The DNA binding domains of UBF represent major human autoepitopes conserved in vertebrates species.

J Bolívar1, C Iglesias, M Ortíz, L Goenechea, A Torres-Montaner, M M Valdivia.   

Abstract

A human autoantigen (NOR-90) previously shown to be the upstream binding factor UBF, binds to the ribosomal RNA genes clustered at the nucleolus organizer regions (NORs). Truncated recombinant forms of hamster UBF were expressed in E. coli and it served to demonstrate that the DNA binding domains of UBF are major autoepitopes as shown by immunoblots analyses with a human autoimmune anti-NOR serum. Several monospecific antibodies to those recombinant truncated UBF polypeptides were generated as shown by immunofluorescence (IF) and Western blots. Immunoblots and IF studies using these anti-UBF sera in cell cultures of various vertebrates species from fish to mammals, indicate the conservation of the DNA binding domains of the ribosomal transcription factor during evolution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10230738

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  3 in total

1.  Histopathological study comparing upstream binding factor expression and AgNOR staining.

Authors:  A Torres-Montaner; M Huq
Journal:  Cell Prolif       Date:  2012-08       Impact factor: 6.831

Review 2.  HMGB proteins involved in TOR signaling as general regulators of cell growth by controlling ribosome biogenesis.

Authors:  A Vizoso-Vázquez; A Barreiro-Alonso; M I González-Siso; E Rodríguez-Belmonte; M Lamas-Maceiras; M E Cerdán
Journal:  Curr Genet       Date:  2018-04-30       Impact factor: 3.886

3.  NOA36 protein contains a highly conserved nucleolar localization signal capable of directing functional proteins to the nucleolus, in mammalian cells.

Authors:  Ivan S de Melo; Maria D Jimenez-Nuñez; Concepción Iglesias; Antonio Campos-Caro; David Moreno-Sanchez; Felix A Ruiz; Jorge Bolívar
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.